Compare · ADUS vs WGS
ADUS vs WGS
Side-by-side comparison of Addus HomeCare Corporation (ADUS) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADUS and WGS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- ADUS is the larger of the two at $2.32B, about 1.2x WGS ($1.86B).
- WGS has been more active in the news (5 items in the past 4 weeks vs 4 for ADUS).
- ADUS has more recent analyst coverage (16 ratings vs 8 for WGS).
- Company
- Addus HomeCare Corporation
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $2.32B
- $1.86B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2009
- 2020
- News (4w)
- 4
- 5
- Recent ratings
- 16
- 8
Addus HomeCare Corporation
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of March 9, 2021, the company served consumers through 212 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Latest ADUS
- SEC Form 144 filed by Addus HomeCare Corporation
- SEC Form 10-Q filed by Addus HomeCare Corporation
- Addus HomeCare Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Addus HomeCare Announces Third Quarter 2026 Financial Results
- Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call
- Addus HomeCare Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Addus HomeCare downgraded by BofA Securities with a new price target
- Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
- Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
- New insider Bickham W Bradley claimed ownership of 34,678 shares (SEC Form 3)
Latest WGS
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
- GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
- GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
- GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
- GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
- GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)